Ambrosia, a startup that pledges to maintain youthfulness by giving customers transfusions of plasma from young people, is back in business after an FDA notice prevented the company from continuing the maligned and dubious practice. What do you think?
Posted from: this blog via Microsoft Flow.
No comments:
Post a Comment